Sanofi Pasteur ships influenza vaccine to US
Sanofi Pasteur has commenced supply of Fluzone influenza virus vaccine to the US for the adults 65 years of age and older.
Sanofi Pasteur, the vaccine division of Sanofi-aventis, intends to ship around 70 million doses of influenza vaccine for this season.
The company expects to offer two formulations of the vaccines - 0.25ml pediatric dose for children from 6 months 35 months of age and 0.5ml dose for children and adults 36 months and older.
Sanofi Pasteur Commercial Operations senior vice president Damian Braga said with the licensure of Fluzone Intradermal vaccine earlier this year and Fluzone High-Dose vaccine at the end of 2009, for the first time this season.
"Sanofi Pasteur will be offering four influenza vaccine options to help address the unique immunization needs of all age groups in support of public health recommendations for everyone 6 months of age and older to receive an annual influenza immunization," Braga said.
CommentsPost a comment
Comments may be moderated for spam, obscenities or defamation.
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs